Merck plans $250m Singapore manufacturing expansion
Merck & Co is investing $250m (€180m) in its Singapore manufacturing capabilities as part of an expansion push.
Archives for October 23, 2011
Almac to add HPAPI capacity to retain customers’ projects into late phase development
Almac hopes adding high potency API manufacturing capacity at its plant in Craigavon, Northern Ireland will help it retain early phase projects as they move to late-stage development.
Analyst calls for Covance to cut early development capacity
Covance should cut early development capacity as demand is returning slowly and will likely fail to reach prior levels, an analyst said.
FDA plans QbD for clinical trials to cut industry & regulatory monitoring costs
The FDA is working on quality-by-design (QbD) for clinical trials to cut oversight costs for industry and regulators.
Saltigo builds in HPAPI manufacturing space for US and Japanese customers
Fine chemicals manufacturer Saltigo is looking to expand its high potency API (HPAPI) business by targeting the pharmaceutical industry in the US and Japan.
Excipient auditor certification scheme ready for 2012 launch, says IPEC
Industry groups developing certification standards for third-party auditors of pharmaceutical excipient manufacturers say they are ready to launch the scheme next year.